You have to think more like Mero. Ignore that they have a growing pipeline, ignore they have $125M in cash. Ignore that they are about to see a $5M milestone + another $5M milestone once Dacogen see's $100M in sales for aml. Ignore that 4 drugs will have data at ash.
Ignore the possible $30M in increasing revenues that we could start seeing some as soon as the 1Q13. BTW all of the 4Q revenues will be at the 30% figure. JNJ probably already has boots on the ground. It sounds like mero missed a buying opportunity and given that his good pal rory, bragged about selling 1/2 his position at 2.30 range.
As this increases in value, rory and mero have to decided to they chase it or talk it down. They fail to realize, they have neither the wit nor the clout to move this either way. They just watching as this the bus pulls away.
I have more shares than you could ever dream of having.
Biotech investing is hard at best. For every drug approved 100's fail. Billions of dollars lost. Astex has a potential in s110. But It took 5 years to get to phase 1 and most likely another 5 years to get approved if luckly. I have the funds to gamble and I am willing to hold.
That some tough talk from the little lady claiming we were headed to 1.83. You still fumming from selling dem shares. How about that reading problem you had earlier in the week. Maybe you should just post a message to yourself again and again and again.
How's it feel to miss twice a 40 cent move. You have to be the dumbest xxxx on the planet.
Now I'm waiting for Mero to explain the new technology. Can you wake him up.